○Shuichi Kanno1, Shin Yomogida1, Akiyoshi Hara1 (1. Department of Clinical Pharmacotherapeutics, Tohoku Medical and Pharmaceutical University)
Session information
Poster Presentation
(C) Biochemistry
[28P02] 薬理学③
Sun. Mar 28, 2021 9:00 AM - 6:00 PM [Room P02] Poster Presentation (Online)
○Yuka Tamura1, Yosuke Maeda1, Yasuyuki Suzuki1, Masahiro Takeyoshi1 (1. Chemicals Evaluation and Research Institute, Japan)
○Mana Yamaguchi1, Kaori Yasuda1, Miyu Nishikawa1, Shinichi Ikushiro1, Toshiyuki Sakaki1 (1. Dept. Biotech., Grad. Sch. Eng., Toyama Pref. Univ.)
○Keiko Inukai1, Kouji Ikeda1, Ayaka Tajima 1, Waka Ban1 (1. NIVEA-KAO)
○Misaki Iwata1, Hirokazu Yamazaki1, Rui Ogura1, Yuki Shimizu1, Yuichiro Kanno1, Ryota Shizu1, Takuomi Hosaka1, Takamitsu Sasaki1, Kouichi Yoshinari1 (1. Sch. Pharm. of Sci., Univ. of Shizuoka)
○Yoshihiro Hamanaka1, Aya Sato1, Yuko Hattori1, Koji Mizukoshi1 (1. POLA Chemical Industries, Inc.)
○Kazuma Hamada1, Minori Okada1, Misaki Hayashi1, Takashi Mizuma1 (1. Fac. Pharm. Sci., Teikyo Heisei Univ.)
○Meiyan Xuan1, Ayaka Suzuki1, Asumi Horikoshi1, Jun Takayama1, Hirokazu Matsuzaki1, Bo Yuan1, Takeshi Sakamoto1, Mari Okazaki1 (1. Fac. Pharm. Sci., Josai Univ.)
○Misa Yamasaka1, Satoshi Asano1,2, Atsuko Hayata3,4, Takanobu Nakazawa5, Hitoshi Hashimoto3,4,6,7,8, James Waschek9, Yukio Ago1,2,3,10 (1. Sch. Dent., Hiroshima Univ., 2. Grad. Sch. Biomed. Health Sci., Hiroshima Univ., 3. Grad. Sch. Pharmaceut. Sci., Osaka Univ., 4. United Grad. Sch. Child Dev., Osaka Univ., 5. Dept. Biosci., Tokyo Univ. Agr., 6. Grad. Sch. Med., Osaka Univ., 7. Inst. Datability Sci., Osaka Univ., 8. Inst. Open Transdiscip. Res. Initiatives, Osaka Univ., 9. UCLA, 10. Global Ctr., Med. Eng. Inform., Osaka Univ.)
○Toru Hosoi1, Takenori Matsuura2, Anisia Silva3, Momoe Wada2, Syu Matsuzaki2, Michitaka Sugiyama2, Naoshi Kodama2, Ralf Jockers3, Julie Dam3, Koichiro Ozawa2 (1. Dept. Clin. Pharmacology, Facul. Pharmaceutical Sci., 2. Dept. Pharmacotherapy, Grad. Sch. Biomed. Health Sci., 3. Inserm, Dept. Endocrinol., Metab. and Diabetes, Paris, France)
○Chinatsu Kaneko1, Sachiko Kuriyama1, Yuka Fujimata1, Hiroka Takase1, Hikaru Sakamoto1 (1. Sch. Pharm., Kitasato Univ.)
○Sota Koike1, Mana Inoue1, Asami Kezuka1, Hiroka Takase1, Hikaru Sakamoto1 (1. Sch. Pharm., Kitasato Univ.)
○Mayumi Kamigaki1, Katsuhiro Tashima1, Miho Tanaka1, Momoko Hirata1, Saki Kanda1, Yasushi Kodama1, Kumatoshi Ishihara1 (1. Lab. of Pharmacol. and Pathophysiol., Hiroshima Int. Univ.)
○Sachiko Hiraide1, Takuji Machida1, Shota Takihana1, Mikoto Ohshita1, Kenji Iizuka1 (1. Dept. of Pharmacol. Sci., Schl. of Pharmaceut. Sci., Health Sci. Univ. of Hokkaido)
○Takaya Misao1, Keijo Fukushima1, Hiromichi Fujino1 (1. Pharmacol. Life Sci. Faclt. Pharmaceutical Sci., Tokushima Univ.)
○Yuu Miyauchi1,2, Akane Kimura2, Madoka Esaki1, Keiko Fujimoto2, Yuko Hirota2, Shinji Takechi1, Yuji Ishii2, Yoshitaka Tanaka2 (1. Fac. Pharmaceut. Sci., Sojo Univ., 2. Grad. Sch. Pharmaceut. Sci., Kyushu Univ.)
[28P02-140] Thiol reducing agents enhance the neurotoxicity of anti-neuron specific enolase antibody
○Yasuhiro Yamamoto1, Hiromi Koma1, Tatsurou Yagami1 (1. Fac. Pharmaceut. Sci., Himeji Dokkyo Univ.)
○Hiromi Koma1, Yasuhiro Yamamoto1, Tatsurou Yagami1 (1. Fac. Pharmaceut. Sci., Himeji Dokkyo Univ.)
○Tatsurou Yagami1, Yasuhiro Yamamoto1, Hiromi Koma1 (1. Fac. Pharmaceut. Sci., Himeji Dokkyo Univ. )
[28P02-143S] High glucose enhances cell death induced by oxidative stress in cultured neuronal cells
○Tokiyo Yamaguchi1, Yuki Ishimaru1, Reina Miura1, Akinori Tanirura1, Akiko Yamamuro1, Yasuhiro Yoshioka1, Sadaaki Maeda1 (1. Fac. Pharmaceut. Sci., Setsunan Univ.)
○Misa Takahashi1, Yasuhiro Kosuge1, Hiroko Miyagishi1, Kumiko Ishige1 (1. Lab. Pharmacol., Sch. Pharma., Nihon Univ.)
○Masaru Doshi1, Shiro Watanabe2, Yujin Natori3, Makoto Hosoyamada1, Yutaka Akae4 (1. Faculty of Pharm-Sciences, Teikyo University, 2. Institute of Natural Medicine, University of Toyama, 3. Department of Legal Medicine and Bioethics, Nagoya University Graduate School of Medicine, 4. Akae clinic)
○Sara Jodai1, Ryota Mori1, Hideto Naka1, Minato Ishida1, Saki Shinto1, Sachiko Kaidzu2, Masaki Tanito2, Yuta Matsuoka1,3, Ken-ichi Yamada1,3 (1. Grad. Sch. Pharm. Sci., Kyushu Univ. , 2. Sch. Med., Shimane Univ., 3. AMED-CREST)
○Masami Abe1, Marie Sou1, Yuta Matsuoka1,2, Ken-ichi Yamada1,2 (1. Grad. Sch. Pharm. Sci., Kyushu Univ., 2. AMED-CREST)
○Momoka Iwamoto1, Yoki Nakamura1, Kazue Nakashima1, Norimitsu Morioka1 (1. Grad. Sch. Biomed. Health Sci., Hiroshima Univ.)
○Nozomi Tokunaga1, Yoki Nakamura1, Kazue Nakashima1, Norimitsu Morioka1 (1. Grad. Sch. Biomed. Health Sci., Hiroshima Univ.)
○Natsuki Yoshimoto1, Kazue Nakashima2, Youki Nakamura2, Norimitsu Morioka2 (1. Sch. Pharm. Sci., Hiroshima Univ., 2. Grad. Sch. Biomed. Health Sci., Hiroshima Univ.)
○Nodoka Shimogaki1, Kohei Mori2, Naoki Shirota2, Tadashi Nakagawa3, Keiko Kitagawa4, Yuhki Yanase2, Toru Hosoi3, Koichiro Ozawa2 (1. Dept. Pharmacotherapy, Sch. Pharm. Hiroshima Univ., 2. Dept. Pharmacotherapy, Grad. Sch. Biomed. Health Sci., Hiroshima Univ., 3. Dept. Clin. Pharmacology, Facul. Pharmaceutical Sci., Sanyo-Onoda City Univ., 4. Dept. Environment. Health, Univ. of Occupational Environment. Health)
○Takahiro Shimizu1, Hideaki Ono1,2, Suo Zou 1, Yamamoto Masaki1, Yohei Shimizu1,2, Yurika Hata1,2, Takaaki Aratake1,3, Shogo Shimizu1, Youichirou Higashi1, Motoaki Saito1 (1. Kochi Med. Sch., Kochi Univ., 2. Center for Innovative and Translational Medicine, Kochi Med. Sch., Kochi Univ., 3. Research Fellow of JSPS)
○Satoru Mitazaki1, Sumiko Abe2, Mamoru Fukuchi1 (1. Lab. of Mol. Neurosci., Fac. of Pharm., Takasaki Univ. of Health and Welfare , 2. Lab. forensic Toxicol., Fac. of Pharm., Takasaki Univ. of Health and Welfare )
○Hiromi Shizunaga1, Masayoshi Mori1, Hiroyoshi Harada1, Yuki Tajiri1, Masaaki Ueno1, Shunsuke Kawanabe1, Yusuke Murata1, Kenji Ohe1, Munetika Enjyoji1 (1. Dpt Pharmacotherapeutics, Fac Pharmaceut Sci, Fukuoka Univ)
○Shunya Nakatsuji1, Ayato Yamada1, Naoki Hattori1 (1. Pharmaceutical Sciences, Ritsumeikan Univ.)
○nanaco masuda1, mana mitutani1, midori matusita1, mika kazitani1, kumi futawaka1, tetuya tagami2, kenzi moriyama1,2 (1. Mukogawa Women's University Faculty of Pharmaceutical Sciences, 2. Clinical Research Center, National Hospital Organization Kyoto Medical Center)
○Mana Mitsutani1, Midori Matsushita1, Nanako Masuda1, Mika Kajitani1, Kumi Futawaka1, Tetsuya Tagami2, Kenji Moriyama1,2 (1. Graduate School of Pharmaceutical Sciences , Mukogawa Women’s Universitiy., 2. Division of Endocrinology , Metabolism and Hypertension , Clinical Reseach Institute , Kyoto Medical Center , National Hospital Organization.)
○Naoto Hashimoto1, Reiko Iwadate1, Hiroshi Kawai1 (1. Fac. Pharm. Pharmaceut. Sci., Josai Univ.)
○Ayaka Otomo1, Megumi Furukawa2, Asaka Imai1, Kentaro Isido1, Yuma Nanjo1, Akihide Sumino1, Kohsuke Hayamizu1, Makoto Nakano1, Tatsuo Hoshino3, Nobuo Izumo1 (1. Lab of Food Chem. Yokohama Univ. Pharm., 2. Center for Pharmaceutical Education., 3. NRL Pharma, Inc.)
○Shigeyoshi Honma1, Suzuka Ota1, Kazuma Komine1, Kohei Toriyabe1, Makoto Yoshida1 (1. Fac. Pharmacy, Takasaki University of Health and welfare)
○Sanehide Hokama1, Saki Maeda1, Junpei Mimaki1, Tomomi Abe1, Takashige Kawakami1, Kojun Setsu1, Masahisa Inoue1 (1. Faculty of pharmaceutical sciences tokushima bunri university)
○Yoshitaka Kihira1, Yoshino Fujimura1, Eiji Sato1 (1. Fac. Pharm. & Pharmaceut. Sci., Fukuyama Univ.)
○Takumi Okamoto1, Kazunori Imaizumi2, Masayuki Kaneko1 (1. Grad. Sch. Biomed. Sci., Nagasaki Univ., 2. Grad. Sch. Biomed. Health Sci., Hiroshima Univ.)
○Satoru Nihei1,2, Hiroaki Takahashi1,2, Junichi Asaka1,2, Kenzo Kudo1,2 (1. Department of Clinical Pharmaceutics and Pharmacy Practice, School of Pharmacy, Iwate Medical University, 2. Department of Pharmacy, Iwate Medical University Hospital)
○Yuto Sekiguchi1, Yusuke Hirata1, Takuya Noguchi1, Atsushi Matsuzawa1 (1. Lab. of Health Chem., Grad. Sch. of Pharmaceut. Sci., Tohoku Univ.)
○Tokuyuki Yoshida1, Yuki Naito2, Yoshinori Tsukumo1, Takayoshi Suzuki1, Nobumichi Ohoka1, Takenori Yamamoto1, Eriko Uchida1, Takao Inoue1 (1. NIHS, 2. DBCLS)
○Yoshinori Tsukumo1, Takayoshi Suzuki1, Tokuyuki Yoshida1, Nobumichi Ohoka1, Takenori Yamamoto1, Eriko Uchida1, Takao Inoue1 (1. Division of Molecular Target and Gene Therapy Products, National Institute of Health Sciences)
○Rie Arai1, Hidetomo Kikuchi2, Yoshio Nishimura3, Hidetsura Cho4 (1. Futaba Nutr. Coll., 2. Fac. Pharm. Pharmaceut. Sci., Josai Univ., 3. Fac. Pharm., Yasuda Women's Univ., 4. Grad. Sch. Pharmaceut. Sci., Tohoku Univ.)
○Hidetomo Kikuchi1, Yoshio Nishimura2, Takanori Kubo2, Bo Yuan1, Katsuyoshi Sunaga1, Hidetsura Cho3 (1. Fac. Pharm. Pharmaceut. Sci., Josai Univ., 2. Fac. Pharm., Yasuda Women's Univ., 3. Grad. Sch. Pharmaceut. Sci., Tohoku Univ.)
○Makoto Koizumi1,2, Ami Matsumura1,3, Yasuo Shinohara1,2,3, Takenori Yamamoto1,4 (1. Inst. Genome Res., Tokushima Univ., 2. Grad. Sch. Pharm. Sci., Tokushima Univ., 3. Pharm. Sci., Tokushima Univ., 4. NIHS)
○Natsumi Hattori1,2, Asuka Kaizaki-Mitsumoto1,2, Takashi Ashino1,2, Masayuki Yamamoto3, Satoshi Numazawa1,2 (1. Pharm. Sci., Showa Univ., 2. SUPRC, 3. Grad. Sch. Med. Sci., Tohoku Univ.)
○Yushi Katsuyama1, Koichi Hiyama2, Yuri Okano1, Hitoshi Masaki3 (1. CIEL CO., LTD., 2. SSP CO., LTD., 3. Tokyo University of Technology)
○Tomoyuki Sato1, Akinori Takemura1, Kousei Ito1 (1. Grad. Sch. Pharm. Sci., Chiba Univ.)
○Takayoshi Mamiya1, Hiroshi Oda1, Tohya Morishita1, Masayuki Hiramastu1 (1. Dept. Chem. Pharmacol., Fac. Pharm., Meijo Univ.)
○Masanori Takahashi1,2, Kouji Okada1,2, Kensuke Usui1,2, Ryusuke Ouchi1,2, Hiroyuki Suzuki1,2, Taisuke Konno1,2, Hitoshi Nakamura1, Takayuki Kogure3, Mari Satoh3, Kennichi Satoh3, Yoshiteru Watanabe1,2, Yuriko Murai1 (1. Pharm. Sci., Tohoku Med. and Pharm. Univ., 2. Tohoku Med. and Pharm. Univ. Hosp., Pharmacy, 3. Tohoku Med. and Pharm. Univ. Hosp., Gastroenterology)
○Takahiro Maeda1, Hiroshi Tsuneki1, Masanori Sugiyama1, Hinako Ishizuka1, Tsutomu Wada1, Sasaoka Toshiyasu1 (1. Dpt. Clin. Pharmacol., Univ. Toyama)